Karadurmus, N. Et Al. 2021. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study. ARCHIVES OF MEDICAL SCIENCE , vol.17, no.4 , 920-927.

Karadurmus, N., PAYDAŞ, S., Esin, E., Surmeli, Z. G., Yildiz, B., Erturk, I., ... Nayir, E.(2021). Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study. ARCHIVES OF MEDICAL SCIENCE , vol.17, no.4, 920-927.

Karadurmus, Nuri Et Al. "Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study," ARCHIVES OF MEDICAL SCIENCE , vol.17, no.4, 920-927, 2021

Karadurmus, Nuri Et Al. "Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study." ARCHIVES OF MEDICAL SCIENCE , vol.17, no.4, pp.920-927, 2021

Karadurmus, N. Et Al. (2021) . "Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study." ARCHIVES OF MEDICAL SCIENCE , vol.17, no.4, pp.920-927.

@article{article, author={Nuri Karadurmus Et Al. }, title={Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study}, journal={ARCHIVES OF MEDICAL SCIENCE}, year=2021, pages={920-927} }